He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Positions Curium as leading manufacturer of Lu-177 isotope
The freshly infused capital will primarily be deployed towards expansion and research & development
Prior to joining Neuland, Deshmukh held several key positions at Cipla
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Previously, Sujatha has held leadership positions at prominent organizations, including Publicis Sapient, Infinite Computer Solutions, and Capgemini
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients with heart failure
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Subscribe To Our Newsletter & Stay Updated
